---
title: Brava and Fat Transfer for Breast Reconstruction
nct_id: NCT02583607
overall_status: UNKNOWN
phase: PHASE1, PHASE2
sponsor: Shaare Zedek Medical Center
study_type: INTERVENTIONAL
primary_condition: Fat Necrosis of Breast
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT02583607.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT02583607"
ct_last_update_post_date: 2015-10-22
last_seen_at: "2026-05-12T06:32:48.813Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Brava and Fat Transfer for Breast Reconstruction

**NCT ID:** [NCT02583607](https://clinicaltrials.gov/study/NCT02583607)

## Key Facts

- **Status:** UNKNOWN
- **Phase:** PHASE1, PHASE2
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 50
- **Lead Sponsor:** Shaare Zedek Medical Center
- **Conditions:** Fat Necrosis of Breast
- **Start Date:** 2015-10
- **Completion Date:** 2017-10
- **CT.gov Last Update:** 2015-10-22

## Brief Summary

Breast reconstruction is one of the most challenging aspects in plastic surgery. One of the most sophisticated methods of breast reconstruction is using of autologous fat grafting. Brava is a device that invented by Dr Roger Khouri, and is intended to improve the final results of fat grafting.

## Detailed Description

The purpose of the study is to examine the efficacy of Brava with fat grafting in woman undergoing mastectomy in the institution. Woman who will agree to participate in the study will be instructed how to wear the Brava, and after 200 hours of using the device they will be operated for fat transfer to the breast in order to reconstruct it.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** FEMALE
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* woman after mastectomy

Exclusion Criteria:

* smokers
* collagen disease
* low compliance
```

## Arms

- **Brava and fat transfer** (EXPERIMENTAL) — The purpose of the study is to examine the efficacy of Brava with fat grafting in woman undergoing mastectomy in the institution.

Woman who will agree to participate in the study will be instructed how to wear the Brava, and after 200 hours of using the device they will be operated for fat transfer to the breast in order to reconstruct it.

## Interventions

- **Brava** (DEVICE) — The purpose of the study is to examine the efficacy of Brava with fat grafting in woman undergoing mastectomy in the institution.

woman who will agree to participate in the study will be instructed how to wear the Brava, and after 200 hours of using the device they will be operated for fat transfer to the breast in order to reconstruct it.

## Primary Outcomes

- **Number of patients satisfied with breast reconstruction using Brava and fat transfer** _(time frame: 6 months)_ — patients undergoing breast mastectomy will undergo breast reconstruction using the Brava and fat transfer, and will be assessed by a certified plastic surgeon who will not be a part of the study.

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT02583607.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT02583607*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*